Without Boundaries
In this episode of Without Boundaries, host Jon Eggins sits down with Matt DeCicco, a leader on Lord Abbett’s equity investment team and portfolio manager on the firm’s Innovation Growth Equity team, with a focus on biotech and healthcare innovation. With an MS in Biotechnology, Matt combines deep scientific expertise with decades of equity investing experience. Topics include: • Why biotech investing is a repeatable process even when revenues are years away * The small-cap opportunities in oncology and rare diseases * How conviction, clinical evidence and price trends impact portfolio allocations * The role of AI in speeding drug discovery and creating differentiation across companies * Developing Russell Investments’ customized biotech strategy for high-growth healthcare
12 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de Without Boundaries!